EPISODE · May 15, 2026 · 7 MIN
[TOP STORY] Compounded weight-loss drugs raise serious patient safety concerns
from Moneyweb@Midday · host Jeremy Maggs
‘I think the main concern with compounded GLP-1s, is that they are not actually assessed or tested by the applicable regulators,’ says Charles Green, healthcare and pharmaceutical expert at Cliffe Dekker Hofmeyr. Moneyweb
What this episode covers
‘I think the main concern with compounded GLP-1s, is that they are not actually assessed or tested by the applicable regulators,’ says Charles Green, healthcare and pharmaceutical expert at Cliffe Dekker Hofmeyr.
NOW PLAYING
[TOP STORY] Compounded weight-loss drugs raise serious patient safety concerns
No transcript for this episode yet